Dormer Laboratories

Name

Dormer Laboratories

Legal name

Dormer Laboratories Inc.

Website

https://dormer.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Medical Devices & Dermatological Products

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Pharmaceutical Preparations (2834)

akta.pro primary industry

Contact Dermatitis & Patch Testing (HLAKACAK)

akta.pro secondary industries

Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Dermatological diagnostics
• Patch testing haptens
• Wart treatment products
• Medical device distribution
• Consumer skincare

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Professional Healthcare Products: B2B sales of dermatological diagnostic and treatment products to healthcare professionals including patch testing haptens, wart removers, medical devices, and medicated shampoos. Products require accounts to order and are sold directly through dormer.com platform.
2. Consumer Skincare (Dormer 211): Over-the-counter skincare and shampoo products sold through retail pharmacies, supermarkets, and directly via Dormer211.com consumer website.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Dormer Laboratories distributes and supplies dermatological diagnostic and treatment products to healthcare professionals across North America, including Chemotechnique patch testing haptens (430+ Health Canada registered allergens) with proprietary IQ Chamber technology, Cantharone cantharidin-based wart removers manufactured under GMP in Canada, Acuderm sterile biopsy punches and curettes, and consumer skincare lines (Dormer 211, Z-Plus shampoo). The company operates a B2B ordering platform for licensed practitioners and a separate direct-to-consumer channel (Dormer211.com) plus Canadian pharmacy distribution for OTC skincare.

Product overview

Dormer Laboratories offers a diversified portfolio of medical diagnostic and treatment products distributed across North America to healthcare professionals and consumers. The portfolio comprises five core product lines: (1) Chemotechnique patch testing haptens (430+ allergens) for allergic contact dermatitis diagnosis using proprietary IQ Chamber technology; (2) Cantharone wart removers (cantharidin-based formulations) for dermatological treatments; (3) Acuderm medical devices including biopsy punches, curettes, and diagnostic media; (4) Dormer 211 consumer skincare with hyaluronic acid complex; and (5) Z-Plus medicated shampoo for dandruff management. The company operates primarily as a distributor for third-party brands (Chemotechnique from Sweden, Acuderm from the US) while manufacturing its own branded products (Cantharone, Dormer 211, Z-Plus). Products target dermatologists, physicians, and consumers across Canada and the USA.

Differentiator

Problem solved

Functional benefit

Brands

• Chemotechnique: Everything for Patch Testing - Health Canada registered haptens and accessories for practitioners. Includes IQ-ULTRA and IQ-ULTIMATE patch test units.
• Cantharone
• Acuderm
• Dormer 211
• Z-Plus Shampoo

Products and services

• Chemotechnique Patch Testing Health Canada registered haptens (430+) for allergic contact dermatitis patch testing, including the aluminum-free IQ Chamber available in IQ-ULTRA and water-resistant IQ-ULTIMATE patch test units. Sold to dermatologists and allergy specialists via the authenticated dormer.com B2B platform. Dormer Laboratories is the exclusive North American distributor.
• Cantharone Wart Removers Cantharidin-based topical wart treatments manufactured in Canada under GMP. Cantharone Liquid (0.7% cantharidin) treats molluscum contagiosum, common and periungual warts; Cantharone PLUS (1% cantharidin, 2% podophyllin, 30% salicylic acid) treats plantar and resistant keratinized warts. Sold to physicians for in-office application. Not approved for sale in the USA.
• Acuderm Medical Devices Sterile disposable biopsy punches (1mm–12mm, 14 sizes), curettes (1mm–7mm in cup and loop shapes), and ACU-DTM fungus test media. Registered with the FDA, Health Canada, and European health authorities. Sold to medical practitioners performing dermatological surgery and biopsy procedures.
• Dormer 211 Skincare Consumer skincare line featuring an exclusive hyaluronic acid complex plus additional moisturizers. Includes face creams with SPF15/SPF30, HyperEmollient for eczema and dry skin, and Oil-Free Fluid Moisturizer for acne-prone skin. Hypoallergenic, fragrance-free. Available OTC in Canadian pharmacies and direct-to-consumer via Dormer211.com.
• Z-Plus Medicated Shampoo Medicated shampoo containing zinc pyrithione for managing dandruff and seborrheic dermatitis. Features a proprietary formula with built-in hair conditioning agents. Safe for use starting at age 2. Sold through Canadian pharmacies, supermarkets, and Dormer211.com.
• Metal Allergy Products Specialized patch testing haptens for metal allergy detection, distributed as part of the Chemotechnique portfolio. Sold to dermatologists and allergy specialists performing contact dermatitis diagnostics.

Quantifiable outcome

• 430+ Health Canada registered haptens available for patch testing
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Chemotechnique MB Diagnostics ABcoreChannel Partner/ Reseller/ Distributor · 1 January 1991Since 1991, Dormer Laboratories has been the exclusive North American distributor for Chemotechnique MB Diagnostics AB (Sweden), a recognized global leader in allergic contact dermatitis patch testing. Chemotechnique's portfolio includes 430+ Health Canada registered haptens. The exclusive Chemotechnique 'IQ' Chamber is aluminum-free and utilized on the advanced IQ-ULTRA and water-resistant IQ-ULTIMATE patch test units.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• SmartPractice: US-based specialty distributor of dermatology, allergy, and patch testing supplies to healthcare professionals, including the T.R.U.E. Test patch test system. Closest direct competitor in business model, customer base, and product category overlap with Dormer's Chemotechnique distribution.
• Chemotechnique MB Diagnostics AB: Swedish manufacturer of the patch testing haptens and IQ Chamber technology that Dormer exclusively distributes in North America. Functions as both supplier and category-defining peer — any direct Chemotechnique entry into North American distribution would displace Dormer.
• Prestige Consumer Healthcare: Owner of Compound W, the leading OTC wart treatment brand in the US and Canada. Direct competitor in the dermatology OTC wart removal space where Dormer's Cantharone competes for physician and patient mindshare.

Broad incumbents

• McKesson: Largest North American pharmaceutical wholesaler with extensive dermatology product distribution. Competes with Dormer's B2B drug distribution model at the larger healthcare system and group practice level.
• Kenvue: Consumer health company behind Aveeno and Neutrogena dermatology skincare brands. Competes with Dormer 211 in Canadian pharmacy and supermarket OTC channels for sensitive skin and eczema-prone consumers.
• Beiersdorf: Owner of Eucerin and La Roche-Posay, two leading medical-grade skincare brands that compete with Dormer 211 in the dermatologist-recommended OTC skincare category across Canadian retail.
• Cardinal Health: Major medical products distributor serving physician offices, ambulatory surgery centers, and dermatology practices. Represents competitive pressure on specialty distributors as purchasing consolidates.
• Becton Dickinson (BD): Global medical device manufacturer with broad biopsy, dermatology, and surgical instrument portfolios. Provides competitive pressure on Acuderm biopsy punches that Dormer distributes in the Canadian market.
• Henry Schein: Large medical and dental distributor with a dermatology segment serving physician practices. Represents the broad-incumbent competitive threat as group practices consolidate purchasing into large wholesalers.
• Integra LifeSciences: Diversified medical device company with significant dermatology and surgical tissue products including biopsy instruments. Competes with Acuderm-branded biopsy punches and curettes that Dormer distributes in Canada.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dormer-laboratories

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dormer Laboratories